| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/22/2004 | US20040014066 Contacting a sample with a transformed microorganism which contains a nucleic acid encoding a promoter operably linked to a heterologous reporter gene capable of causing detecatable signal, observing microorganism for such signal |
| 01/22/2004 | US20040014065 Method for determining the likelihood that a test polynucleotide sequence differs from a driver polynucleotide |
| 01/22/2004 | US20040014064 Therapeutics and diagnostics for disorders of erythropoiesis |
| 01/22/2004 | US20040014063 Detecting IL-6 mRNA by direct detection of IL-6 through immuno-chromatography for forecasting impending preterm deliveries |
| 01/22/2004 | US20040014062 Contacting at least two differently radiolabelled nucleic acid samples on a nucleic acid array, and analyzing nucleic acids in the samples by detecting hybrids formed between the nucleic acids of the sample and the nucleic acid array |
| 01/22/2004 | US20040014061 Hypha-specific factors from candida albicans |
| 01/22/2004 | US20040014060 Doped nanoparticles as biolabels |
| 01/22/2004 | US20040014059 Quantifying RNA from a blood sample, detecting expression of a gene in the quantified RNA, wherein the expression of gene in quantified RNA indicates expression of such gene in the blood; for an immediate accurate diagnostic/prognostic test for |
| 01/22/2004 | US20040014058 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 01/22/2004 | US20040014057 Targeted chromosomal genomic alterations with modified single stranded oligonucleotides |
| 01/22/2004 | US20040014056 Identification of genetic markers |
| 01/22/2004 | US20040014055 Gene coding for erbin, and diagnostic and therapeutic uses thereof |
| 01/22/2004 | US20040014045 Detection of ligand/antiligand complex formation by electromagnetically detectable bulk property measurement |
| 01/22/2004 | US20040014042 Multiplex genotyping using solid phase capturable dideoxynucleotides and mass spectrometry |
| 01/22/2004 | US20040014041 Facilitates the design of artifacts by a process of participative refinement; this process being analogous to natural selection as it operates in biological populations |
| 01/22/2004 | US20040014040 Identification of toxicity markers in tissues or cells exposed to a known cardiotoxin; the genes may be used as toxicity markers in drug screening and toxicity assays |
| 01/22/2004 | US20040014039 Nucleic acids, proteins, and antibodies |
| 01/22/2004 | US20040014037 Release factors (RF-1) polypeptides and DNA (RNA) encoding RF-1 polypetides and methods for producing such polypeptides by recombinant techniques; utilizing RF-1 polypeptides to screen for antibiotics |
| 01/22/2004 | US20040014035 Methods for producing transgenic plants containing evolutionarily significant polynucleotides |
| 01/22/2004 | US20040014033 Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics |
| 01/22/2004 | US20040014030 Enzymatic assay of HIV protease inhibitors |
| 01/22/2004 | US20040014027 Used in determining the extent of tissue damage caused by the infection as well as in determining the stage of disease progression of the HCMV infection |
| 01/22/2004 | US20040014026 Methods for identifying compounds that inhibit ubiquitin-mediated proteolysis of IkappaB |
| 01/22/2004 | US20040014023 A biosensor with an electrochemical-enzymatic sensor that has a working electrode and a reference electrode; used in fluids contaminated with microorganisms such as bacteria, wherein the device detects oxygen consumption by the organism |
| 01/22/2004 | US20040013739 Membrane fractions of 1,2-sn-diacylglycerol-enriched cells |
| 01/22/2004 | US20040013691 Immunotoxin as a therapeutic agent and uses thereof |
| 01/22/2004 | US20040013683 Polypeptide viricides; genetic engineering |
| 01/22/2004 | US20040013673 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram posiive bacteria |
| 01/22/2004 | US20040013668 Polypeptide antibody which binds to low density lipoprotein; quantitative analysis |
| 01/22/2004 | US20040013664 Antiinflamamtory agents; antiallergens; antihistamines |
| 01/22/2004 | US20040013663 Using nucleic acids for diagnosis; monitoring efficiency of drug |
| 01/22/2004 | US20040013655 Mutant Dna; transcription of genomes |
| 01/22/2004 | US20040013575 For collecting a biological sample, particularly whole blood, includes at least one stabilizing agent in an amount effective to stabilize and inhibit protein degradation and/or fragmentation |
| 01/22/2004 | US20040013573 Used to synthesize nucleic acid arrays |
| 01/22/2004 | US20040011671 Device and method for determining analyte levels |
| 01/22/2004 | US20040011650 Method and apparatus for manipulating polarizable analytes via dielectrophoresis |
| 01/22/2004 | US20040011643 Electrode |
| 01/22/2004 | DE20315159U1 Kit for diagnostic detection of severe acute respiratory syndrome-associated virus, comprises primers and probes for a real-time reverse transcription polymerase chain reaction |
| 01/22/2004 | DE10230631A1 Verwendungen von an Ngal bindenden Substanzen zur Diagnose und Behandlung von Krebserkrankungen Uses of binding of NGAL substances for the diagnosis and treatment of cancer |
| 01/22/2004 | DE10228260A1 Methode und Vorrichtung zum impedimetrischen Nachweis eines oder mehrerer Analyten in einer Probe Method and apparatus for impedimetric detection of one or more analytes in a sample |
| 01/22/2004 | DE10227599A1 Verfahren und Reagenz zur spezifischen Identifizierung und Quantifizierung von einem oder mehreren Proteinen in einer Probe The method and reagent for the specific identification and quantification of one or more proteins in a sample |
| 01/22/2004 | CA2493675A1 Genes |
| 01/22/2004 | CA2493111A1 Diagnosis and prevention of cancer cell invasion |
| 01/22/2004 | CA2493088A1 Novel method of selecting immunosuppressant having little thrombocytopenic effect |
| 01/22/2004 | CA2492772A1 Activated checkpoint therapy and methods of use thereof |
| 01/22/2004 | CA2492716A1 Brachyspira hyodysenteriae vaccine |
| 01/22/2004 | CA2492662A1 Method for identification of biologically active agents |
| 01/22/2004 | CA2492416A1 Computer user interface facilitating acquiring and analyzing of biological specimen traits |
| 01/22/2004 | CA2492383A1 Transplant acceptance inducing cells of monocytic origin and their preparation and use |
| 01/22/2004 | CA2492355A1 Method for diagnosis of intestinal-type gastric tumors |
| 01/22/2004 | CA2492313A1 Mutant proteins and use thereof for the manufacture of medicaments and the treatment of humans or animals suffering from conformational diseases |
| 01/22/2004 | CA2492288A1 Assaying and imaging system identifying traits of biological specimens |
| 01/22/2004 | CA2492213A1 Detection of target molecules using serrs reactive particles |
| 01/22/2004 | CA2492212A1 Nucleic acid labeling methods |
| 01/22/2004 | CA2492203A1 Synthetic tag genes |
| 01/22/2004 | CA2492068A1 Assays for assembly of ebola virus nucleocapsids |
| 01/22/2004 | CA2491984A1 Nucleic acid amplification method |
| 01/22/2004 | CA2491969A1 Method for identifying individual active entities from complex mixtures |
| 01/22/2004 | CA2491737A1 Method for detection of bioactive peptides |
| 01/22/2004 | CA2491235A1 Chromosome 3, 5 and 11 genes involved in premature canities |
| 01/22/2004 | CA2491223A1 Chromosome 6 and 9 genes involved in premature canities |
| 01/22/2004 | CA2489203A1 Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury |
| 01/22/2004 | CA2489174A1 Rna-interference by single-stranded rna molecules |
| 01/22/2004 | CA2433479A1 Conjugate of a tissue non-specific alkaline phosphatase and dextran, process for its production and use thereof |
| 01/21/2004 | EP1382969A1 Diagnosis and prevention of cancer cell invasion |
| 01/21/2004 | EP1382962A1 Apparatus and method for performing microfluidic manipulations for chemical analysis and synthesis |
| 01/21/2004 | EP1382693A1 Methods and compositions for the detection of pathologic events |
| 01/21/2004 | EP1382692A2 Enzymatic assay of HIV protease inhibitors |
| 01/21/2004 | EP1382691A2 Method for the isolation of the 20S proteasome, and methods for the identification of 20S and 26S proteasome inhibitors |
| 01/21/2004 | EP1382690A1 Method to reduce false positive outcomes in prion assays |
| 01/21/2004 | EP1382689A1 Screening methods for the detection of amidase and nitrile hydratase activities and their use |
| 01/21/2004 | EP1382688A1 Screening method |
| 01/21/2004 | EP1382676A1 A method for separating and purifying a nucleic acid |
| 01/21/2004 | EP1382616A2 Pharmaceutical composition for use in the treatment of abnormalities associated with the activity of a human Y5-receptor |
| 01/21/2004 | EP1382611A2 Bacillus strains and Pesticidal proteins |
| 01/21/2004 | EP1382386A2 Novel oligonucleotide arrays and their use for sorting, isolating, sequencing, and manipulating nucleic acids |
| 01/21/2004 | EP1382351A1 Combination therapy of agiotensin converting enzyme inhibitor and epoxy-steroidal aldosterone antagonist for treatment of cardiovasuclar disease |
| 01/21/2004 | EP1381868A2 Method for testing samples containing prion protein for the possible presence of the prp?sc form |
| 01/21/2004 | EP1381860A2 Models and methods for determining systemic properties of regulated reaction networks |
| 01/21/2004 | EP1381698A2 Method for analysing nucleic acid chains |
| 01/21/2004 | EP1381697A2 Circular probe amplification (cpa) using energy-transfer primers |
| 01/21/2004 | EP1381696A2 Method to analyse the kit genotype of pigs |
| 01/21/2004 | EP1381695A2 Methods of analysis of nucleic acids |
| 01/21/2004 | EP1381694A1 Methods for identifying ligand binding sites in a biomolecule |
| 01/21/2004 | EP1381693A1 Apparatus and method for sequencing a nucleic acid |
| 01/21/2004 | EP1381692A2 Genome-wide location and function of dna binding proteins |
| 01/21/2004 | EP1381691A2 Method of determining a chemotherapeutic regimen based on ercc1 and ts expression |
| 01/21/2004 | EP1381687A2 Cytoplasmic gene inhibition or gene expression in transfected plants by a tobraviral vector |
| 01/21/2004 | EP1381684A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 01/21/2004 | EP1381680A1 Template-mediated, ligation-oriented method of nonrandomly shuffling polynucleotides |
| 01/21/2004 | EP1381679A2 Cell-free assay and in vivo method for plant genetic repair using chloroplast lysate |
| 01/21/2004 | EP1381678A2 Nucleic acid modification enzymes |
| 01/21/2004 | EP1381675A2 Method for replicating the hepatitis c virus |
| 01/21/2004 | EP1381673A1 Compositiona and methods useful for hcv infection |
| 01/21/2004 | EP1381672A1 Biosynthesis of polyketide synthase substrates |
| 01/21/2004 | EP1381670A1 Miniature device for separating and isolating biological objects and uses thereof |
| 01/21/2004 | EP1381629A2 RECEPTOR IN THE EDb FIBRONECTIN DOMAIN |
| 01/21/2004 | EP1381628A2 Inflammation-specific peptides and the uses thereof |
| 01/21/2004 | EP1381626A2 Human transporters and ion channels |
| 01/21/2004 | EP1381625A1 Mutants of green fluorescent protein |